Work

Niraparib, an FDA-Approved Poly-(ADP-Ribose) Polymerase (PARP) Inhibitor Is Renoprotective against Cisplatin Nephrotoxicity in Ovarian Tumor-Bearing Mice

Year: 2024

Type: article

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.2024k2n8z778

Authors: Mira Noh, Amritha Kannan, Babu J. Padanilam

Institution: Icahn School of Medicine at Mount Sinai

Language: English

Topic: Chemotherapy-induced organ toxicity mitigation

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403831989

FWCI: 0.266

Cites:

Cited by: 1

Related to: 10